Shanghai Institute of Material Medical and AS-IV Wuhan Institute of Virology, CAS found that, Shuanghuanglian Oral has results in controlling Novel Coronovirus. It is really a great discovery in this moment. So Shanghai Institute of Material Medical starts the emergency team of drug research for Novel Coronovirus. On the basis of previous SARS related research and drug discovery achievements, focus on the research of new and old medicines.
Shuanghuanglian Oral is consists of Honeysuckle, Scutellaria Baicalensis and Forsythia. The Traditional Chinese doctors believe that these three traditional Chinese medicines have the function of clearing heat and detoxification. Modern medical research suggests that It has the function of spectrum anti-virus, bacteriostasis and improving immune function and It is one of the effective broad-spectrum antiviral drugs.
Shanghai institute of materia medica has long been engaged in the research of antiviral drugs. During SARS in 2003, Zuo jianping's team from Shanghai institute of Material Medical was the first to confirm that shuanghuanglian oral has anti-sars coronavirus effect.
For more than ten years, successively confirm that Shuanghuanglian Oral has good results in antivirals, such as Influenza Virus(H7N9,H1N1,H5N1), SARS and Middle East SARS ect.
At present, Shuanghuanglian Oral has been conducted clinical studies in Shanghai public health clinical center and Tongji Hospital. We’re looking forward to the good news.